シクロフェニル
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/08/18 15:56:26」(JST)
[Wiki en表示]
Not to be confused with Cycloguanil.
Cyclofenil
|
Systematic (IUPAC) name |
[4-[(4-acetoxyphenyl)-cyclohexylidene-methyl]phenyl] acetate |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Legal status |
? |
Routes |
Oral |
Identifiers |
CAS number |
2624-43-3 |
ATC code |
G03GB01 |
PubChem |
CID 2898 |
ChemSpider |
2795 |
UNII |
J468V64WZ1 Y |
KEGG |
D01281 |
ChEMBL |
CHEMBL141305 |
Synonyms |
bis(p-acetoxyphenyl)cyclohexylidenemethane |
Chemical data |
Formula |
C23H24O4 |
Mol. mass |
364.434 g/mol |
SMILES
- O=C(Oc3ccc(C(/c1ccc(OC(=O)C)cc1)=C2\CCCCC2)cc3)C
|
Cyclofenil (INN, trade names Ondogyne, Sexovid, and others) is a selective estrogen receptor modulator.
It was investigated as a possible treatment for scleroderma in the 1980s, but was found to be ineffective.[1] Later study of its efficacy in treating Raynaud's phenomenon in people with scleroderma also found no statistically significant benefit.[2]
References
- ^ Torres MA, Furst DE (February 1990). "Treatment of generalized systemic sclerosis". Rheum Dis Clin North Am 16 (1): 217–41. PMID 2406809.
- ^ Pope J, Fenlon D, Thompson A, et al. (2000). "Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis". In Pope, Janet. Cochrane Database Syst Rev (2): CD000955. doi:10.1002/14651858.CD000955. PMID 10796397.
Estrogenics
|
|
Receptor |
ER (α, β)
|
|
|
GPER
|
- Agonists: Estradiol
- Fulvestrant
- G-1
- Genistein
- Quercetin
- Tamoxifen
|
|
|
Enzyme
(inhibitors) |
20,22-Desmolase
|
- 22-ABC
- 3,3′-Dimethoxybenzidine
- 3-Methoxybenzidine
- Aminoglutethimide
- Cyanoketone
- Danazol
- Etomidate
- Mitotane
- Trilostane
|
|
17α-Hydroxylase,
17,20-Lyase
|
- 22-ABC
- 22-Oxime
- Abiraterone
- Bifonazole
- Clotrimazole
- Cyanoketone
- Cyproterone
- Danazol
- Econazole
- Galeterone
- Gestrinone
- Isoconazole
- Ketoconazole
- L-39
- Liarozole
- LY-207,320
- MDL-27,302
- Miconazole
- Mifepristone
- Orteronel
- Pioglitazone
- Rosiglitazone
- Spironolactone
- Stanozolol
- SU-10,603
- TGF-β
- Tioconazole
- Troglitazone
- VN/87-1
- YM116
|
|
3β-HSD
|
- 4-MA
- Azastene
- Cyanoketone
- Danazol
- Epostane
- Genistein
- Gestrinone
- Metyrapone
- Oxymetholone
- Pioglitazone
- Rosiglitazone
- Trilostane
- Troglitazone
|
|
17β-HSD
|
|
|
Aromatase
|
- 1,4,6-Androstatriene-3,17-dione
- 4-Androstene-3,6,17-trione
- 4-Cyclohexylaniline
- 4-Hydroxytestosterone
- 5α-DHNET
- Abyssinone II
- Aminoglutethimide
- Anastrozole
- Ascorbic acid (Vitamin C)
- Atamestane
- Bifonazole
- CGP-45,688
- CGS-47,645
- Clotrimazole
- DHT
- Difeconazole
- Econazole
- Exemestane
- Fadrozole
- Fenarimol
- Finrozole
- Formestane
- Imazalil
- Isoconazole
- Ketoconazole
- Letrozole
- Liarozole
- MEN-11066
- Miconazole
- Minamestane
- Nimorazole
- NKS01
- ORG-33,201
- Penconazole
- Plomestane
- Prochloraz
- Propioconazole
- Pyridoglutethimide
- Rogletimide
- Rotenone
- Talarozole
- Testolactone
- Tioconazole
- Triadimefon
- Triadimenol
- Troglitazone
- Vorozole
- YM511
- Zinc
Note: 5α-reductase and 21-hydroxylase inhibitors may also affect estrogen levels as they prevent metabolism of estrogen steroid precursors.
|
|
|
Other |
Endogenous
|
- Estrogens: 5α-Androstane-3β,17β-diol
- DHEA
- Estetrol
- Estradiol
- Estriol
- Estrone
- Antiestrogens: 2-Hydroxyestrone
- 16-Hydroxyestrone
- Precursors: Cholesterol
- 22R-Hydroxycholesterol
- 20α,22R-Dihydroxycholesterol
- Pregnenolone
- 17-Hydroxypregnenolone
- Progesterone
- 17-Hydroxyprogesterone
- Cortodoxone/Deoxycortisol
- DHEA
- DHEA sulfate
- 16-Hydroxy-DHEA
- 16-Hydroxy-DHEA sulfate
- Androstenediol
- Androstenedione
- 16-Hydroxyandrostenedione
- Testosterone
|
|
Indirect
|
- Androgens/Antiandrogens (see here)
- Calcitriol (a form of Vitamin D)
- GnRH agonists/antagonists (see here)
- Gonadotropins//Antigonadotropins (see here)
- Plasma proteins (SHBG, ABP, Albumin)
- Progestogens/Antiprogestins (see here)
- Prolactin
|
|
Procedures
|
- Adrenalectomy
- Hypophysectomy
- Oophorectomy
- Orchiectomy
|
|
|
English Journal
- Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis.
- Tingey T, Shu J, Smuczek J, Pope J.SourceMcMaster University, Hamilton, Ontario, Canada.
- Arthritis care & research.Arthritis Care Res (Hoboken).2013 Sep;65(9):1460-71. doi: 10.1002/acr.22018.
- OBJECTIVE: To assess the efficacy of therapies in healing and preventing digital ulcers (DUs) in systemic sclerosis (SSc; scleroderma).METHODS: Medline and EMBASE databases, and American College of Rheumatology and European League Against Rheumatism abstracts, were searched. Randomized controlled tr
- PMID 23554239
- Cyclofenil as a possible cause of non-arteritic anterior ischaemic optic neuropathy.
- Clarke B, Sykakis E, Parmar DN.SourceDepartment of Ophthalmology, Whipps Cross University Hospital, London, UK. esykakis@gmail.com
- BMJ case reports.BMJ Case Rep.2012 Dec 20;2012. pii: bcr2012007825. doi: 10.1136/bcr-2012-007825.
- A 27-year-old woman receiving the steroid drug cyclofenil as a fertility adjunct, experienced blurred vision 24 h after missing a dose and taking a double dose to 'catch up' with her therapeutic protocol. She was found to have a non-arteritic anterior ischaemic optic neuropathy with a visual hemifie
- PMID 23264159
- Treatments for suppression of lactation.
- Oladapo OT, Fawole B.SourceMaternal and Fetal Health Research Unit, Department of Obstetrics and Gynaecology, Obafemi Awolowo College of Health Sciences, Olabisi Onabanjo University, Sagamu, Ogun State, Nigeria. tixon_y2k@hotmail.com.
- The Cochrane database of systematic reviews.Cochrane Database Syst Rev.2012 Sep 12;9:CD005937. doi: 10.1002/14651858.CD005937.pub3.
- BACKGROUND: Various pharmacologic and non-pharmacologic interventions have been used to suppress lactation after childbirth and relieve associated symptoms. Despite the large volume of literature on the subject, there is currently no universal guideline on the most appropriate approach for suppressi
- PMID 22972088
Japanese Journal
- Journal of mammalian ova research = 日本哺乳動物卵子学会誌 20(2), S50, 2003-08-01
- NAID 10011252440
- 子宮内膜脱落膜化モデルを用いた,clomifene citrateおよびcyclofenilの脱落膜化に及ぼす影響の評価
Related Pictures
★リンクテーブル★
[★]
- 英
- cyclofenil
- 商
- セキソビット